» Articles » PMID: 38658796

Dynamic Control of Gene Expression by ISGF3 and IRF1 During IFNβ and IFNγ Signaling

Overview
Journal EMBO J
Date 2024 Apr 24
PMID 38658796
Authors
Affiliations
Soon will be listed here.
Abstract

Type I interferons (IFN-I, including IFNβ) and IFNγ produce overlapping, yet clearly distinct immunological activities. Recent data show that the distinctness of global transcriptional responses to the two IFN types is not apparent when comparing their immediate effects. By analyzing nascent transcripts induced by IFN-I or IFNγ over a period of 48 h, we now show that the distinctiveness of the transcriptomes emerges over time and is based on differential employment of the ISGF3 complex as well as of the second-tier transcription factor IRF1. The distinct transcriptional properties of ISGF3 and IRF1 correspond with a largely diverse nuclear protein interactome. Mechanistically, we describe the specific input of ISGF3 and IRF1 into enhancer activation and the regulation of chromatin accessibility at interferon-stimulated genes (ISG). We further report differences between the IFN types in altering RNA polymerase II pausing at ISG 5' ends. Our data provide insight how transcriptional regulators create immunological identities of IFN-I and IFNγ.

Citing Articles

Cell-type-specific requirement for TYK2 in murine immune cells under steady state and challenged conditions.

Karjalainen A, Witalisz-Siepracka A, Prchal-Murphy M, Martin D, Sternberg F, Krunic M Cell Mol Life Sci. 2025; 82(1):98.

PMID: 40025196 PMC: 11872851. DOI: 10.1007/s00018-025-05625-9.


lncRNA regulates expression and function of innate immune transcription factor IRF1 in macrophages.

Cyr Y, Gourvest M, Ciabattoni G, Zhang T, Newman A, Zahr T Life Sci Alliance. 2025; 8(3).

PMID: 39773901 PMC: 11707381. DOI: 10.26508/lsa.202403021.

References
1.
Abdul-Sater A, Majoros A, Plumlee C, Perry S, Gu A, Lee C . Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs. J Immunol. 2015; 195(1):210-216. PMC: 4617678. DOI: 10.4049/jimmunol.1401139. View

2.
Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, Bornholdt J, Boyd M . An atlas of active enhancers across human cell types and tissues. Nature. 2014; 507(7493):455-461. PMC: 5215096. DOI: 10.1038/nature12787. View

3.
Au-Yeung N, Horvath C . Histone H2A.Z Suppression of Interferon-Stimulated Transcription and Antiviral Immunity Is Modulated by GCN5 and BRD2. iScience. 2018; 6:68-82. PMC: 6137307. DOI: 10.1016/j.isci.2018.07.013. View

4.
Babiarz J, Halley J, Rine J . Telomeric heterochromatin boundaries require NuA4-dependent acetylation of histone variant H2A.Z in Saccharomyces cerevisiae. Genes Dev. 2006; 20(6):700-10. PMC: 1413290. DOI: 10.1101/gad.1386306. View

5.
Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, DAndrea A . Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature. 1996; 383(6598):344-7. DOI: 10.1038/383344a0. View